MZTI: Bachan's-backed Retail gains were outweighed by outbreak-hit volumes and freight costs

What happened

Q1 sales fell 2.4% and diluted EPS dropped to $1.07. Excluding TSA sales and identified one-time items, adjusted sales fell 0.3% and adjusted EPS was $1.14. Cyclospora-related weakness and higher freight costs pressured segments, while Bachan's supported Retail.

Confirmed

Global impact / market context

Weaker sales and a lower profit per share show the company is earning less from each sale. Cyclospora is a foodborne illness that hurt demand in some segments, and higher freight costs raise expenses. Bachan's backing helped Retail, showing brand partnerships can offset weakness elsewhere.

Analyst inference

This is a food company facing uneven demand across segments. Illness-related weakness can reduce volumes, while freight costs add to expenses and squeeze profit. Investors weighing the stock compare adjusted figures that strip out one-time items, since those give a cleaner view of recurring performance.

Analyst inference

What to watch

1. Watch whether Cyclospora-related weakness persists in future quarters, since it reduced volumes in some segments. Confirmed
2. Track freight costs to see if elevated shipping expenses keep pressuring profit, as higher costs reduce earnings per sale. Analyst inference
3. Monitor Retail segment sales tied to Bachan's, because that support offset weakness elsewhere and could continue to help. Analyst inference

Evidence

• Original source link unavailable